Researchers have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers. This work, which involves inhibiting the oncogenic protein RAS using small molecules, lays ...
Scientists at CRISPR Therapeutics have compared three commonly used methods to detect off-target gene editing activity of the CRISPR-Cas9 machinery and found them to be equally adept, although each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results